ID
20054
Beschrijving
NCT01117584 Astellas Phase 2b, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy, Safety and Tolerability of a 12- Week Treatment with ASP1941 in Combination with Metformin in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone.
Trefwoorden
Versies (2)
- 30-12-16 30-12-16 -
- 04-02-17 04-02-17 -
Geüploaded op
4 februari 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
End of Study: End of Treatment/ Premature Discontinuation [DS_1] NCT01117584
End of Study: End of Treatment/ Premature Discontinuation [DS_1] NCT01117584
Similar models
End of Study: End of Treatment/ Premature Discontinuation [DS_1] NCT01117584
C1517741 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1517741 (UMLS CUI [1,2])
C2826182 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0013216 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
C0013216 (UMLS CUI [1,2])
C1522508 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])